Literature DB >> 26379924

Analgesic effect of TAK-242 on neuropathic pain in rats.

Yang Zhao1, Yan Xin2, Jie Gao1, Ru-Yang Teng1, Hai-Chen Chu1.   

Abstract

BACKGROUND: The current study investigated the analgesic effect of the Toll-like receptor 4 (TLR4) specific antagonist TAK-242 on neuropathic pain in rats and its underlying mechanism.
METHODS: A total of 132 adult Sprague-Dawley (SD) rats were randomly divided into four groups: the sham operation group, the neuropathic pain model group, the TAK-242 low-dose treatment group, and the TAK-242 high-dose treatment group. The heat pain and mechanic pain thresholds of rats were detected on preoperative day 1 and postoperative days 1, 3, 7, and 10. The expression levels of IκBα, p65, IL-1β, and TNF-α in the spinal cord dorsal horn were detected on postoperative day 7 in one group of rats.
RESULTS: Compared with rats in the sham operation group, the heat pain and mechanic pain thresholds of the rats in the neuropathic pain model group significantly decreased; their expression levels of p65, IL-1β, and TNF-α significantly increased; and their expression level of IkBα significantly decreased. Compared with the neuropathic pain group, high doses of TAK-242 significantly inhibited the expression of p65, IL-1β, and TNF-α; significantly increased the expression level of IkBα; and upregulated the heat pain and mechanic pain thresholds.
CONCLUSION: TAK-242 might improve neuropathic pain through downregulation of the NF-κB pathway.

Entities:  

Keywords:  Neuropathic pain; TAK-242

Year:  2015        PMID: 26379924      PMCID: PMC4565307     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

1.  Evidence for the role of PI(3) -kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice.

Authors:  Irene Paterniti; Emanuela Esposito; Emanuela Mazzon; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Eur J Neurosci       Date:  2011-04       Impact factor: 3.386

2.  Small interfering RNA-mediated knockdown of NF-κBp65 attenuates neuropathic pain following peripheral nerve injury in rats.

Authors:  Tao Sun; Jiangang Luo; Mingrui Jia; Hui Li; Kezhong Li; Zhijian Fu
Journal:  Eur J Pharmacol       Date:  2012-02-21       Impact factor: 4.432

3.  Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Chun Wang; Peng-Fei Wang; Huang Fang; Jing Chen; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Stroke       Date:  2013-07-09       Impact factor: 7.914

4.  A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.

Authors:  Todd W Rice; Arthur P Wheeler; Gordon R Bernard; Jean-Louis Vincent; Derek C Angus; Naoki Aikawa; Ignace Demeyer; Stephen Sainati; Nicholas Amlot; Charlie Cao; Masayuki Ii; Hideyasu Matsuda; Kouji Mouri; Jon Cohen
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

5.  Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats.

Authors:  Xin Kuang; Yan Huang; Hong-Feng Gu; Xu-Yu Zu; Wang-Yuan Zou; Zong-Bin Song; Qu-Lian Guo
Journal:  Eur J Pharmacol       Date:  2011-12-07       Impact factor: 4.432

Review 6.  TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs.

Authors:  Rodolfo Gómez; Amanda Villalvilla; Raquel Largo; Oreste Gualillo; Gabriel Herrero-Beaumont
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

7.  Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice.

Authors:  Isabella Bettoni; Francesca Comelli; Clara Rossini; Francesca Granucci; Gabriella Giagnoni; Francesco Peri; Barbara Costa
Journal:  Glia       Date:  2008-09       Impact factor: 7.452

8.  The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice.

Authors:  Cataldo Martucci; Anna Elisa Trovato; Barbara Costa; Elisa Borsani; Silvia Franchi; Valerio Magnaghi; Alberto E Panerai; Luigi F Rodella; Anna Elisa Valsecchi; Paola Sacerdote; Mariapia Colleoni
Journal:  Pain       Date:  2007-09-27       Impact factor: 6.961

9.  Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain.

Authors:  Fei-xiang Wu; Jin-jun Bian; Xue-rong Miao; Sheng-dong Huang; Xue-wu Xu; De-jun Gong; Yu-ming Sun; Zhi-jie Lu; Wei-feng Yu
Journal:  Int J Med Sci       Date:  2010-08-02       Impact factor: 3.738

10.  Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.

Authors:  Iciar Gárate; Borja García-Bueno; José Luis Muñoz Madrigal; Javier R Caso; Luis Alou; María Luisa Gómez-Lus; Juan Carlos Leza
Journal:  J Neuroinflammation       Date:  2014-01-11       Impact factor: 8.322

View more
  9 in total

1.  Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes.

Authors:  Liang Liang; Meng-Nan Zhu; Bao-Ji Chen; Zheng Wang; Li-Ye He; Rang Zhang
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

2.  Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.

Authors:  Xiangrong Cui; Xuan Jing; Susan K Lutgendorf; Catherine S Bradley; Andrew Schrepf; Bradley A Erickson; Vincent A Magnotta; Timothy J Ness; Karl J Kreder; Michael A O'Donnell; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

Review 3.  The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy.

Authors:  Seyed Hossein Aghamiri; Khalil Komlakh; Mehran Ghaffari
Journal:  Inflammopharmacology       Date:  2022-01-12       Impact factor: 4.473

4.  Translocation Associated Membrane Protein 1 Contributes to Chronic Constriction Injury-Induced Neuropathic Pain in the Dorsal Root Ganglion and Spinal Cord in Rats.

Authors:  Dekun Yin; Yonglin Chen; Rongxiang Lu; Bingbing Fan; Shunxing Zhu; Xingguo Xu; Zhongling Xu
Journal:  J Mol Neurosci       Date:  2018-10-18       Impact factor: 3.444

5.  Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.

Authors:  Xiao-Qian Li; Zai-Li Zhang; Wen-Fei Tan; Xi-Jia Sun; Hong Ma
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

6.  Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity.

Authors:  Mónica Tramullas; Beate C Finger; Timothy G Dinan; John F Cryan
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

7.  Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine.

Authors:  Min Su; Ye Ran; Zizi He; Mingjie Zhang; Guanqun Hu; Wenjing Tang; Dengfa Zhao; Shengyuan Yu
Journal:  Mol Pain       Date:  2018-01-08       Impact factor: 3.395

8.  Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.

Authors:  Agnieszka M Jurga; Ewelina Rojewska; Wioletta Makuch; Joanna Mika
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

9.  TLR4/NF-κB signaling activation in plantar tissue and dorsal root ganglion involves in the development of postoperative pain.

Authors:  Fei Xing; Wei Zhang; Jing Wen; Liying Bai; Hanwen Gu; Zhisong Li; Jian Zhang; Yuan-Xiang Tao; Ji-Tian Xu
Journal:  Mol Pain       Date:  2018-10-01       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.